LAMP1 and type 2 diabetes mellitus: Metformin, the first-line agent in type 2 diabetes treatment, was reported to increase LC3II, p62 and Lysosomal associated membrane protein 1 (LAMP1) expression levels, which further enhanced the level of autophagy.